Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y
Signal Transduct Target Ther. 2025; 10(1):93.
PMID: 40055311
PMC: 11889221.
DOI: 10.1038/s41392-025-02124-y.
Pudgerd A, Pluangnooch P, Soontrapa K, Saedan S, Vanichviriyakit R, Sridurongrit S
Heliyon. 2025; 11(4):e42691.
PMID: 40040984
PMC: 11876931.
DOI: 10.1016/j.heliyon.2025.e42691.
Kim S, Kim Y, Kim S, Choi Y, Lee I, Joo H
Nat Commun. 2025; 16(1):1903.
PMID: 39988725
PMC: 11847939.
DOI: 10.1038/s41467-025-57133-w.
Cho Y, Kwon Y, Hwang S
Liver Res. 2025; 7(1):16-25.
PMID: 39959694
PMC: 11791820.
DOI: 10.1016/j.livres.2022.06.001.
Chen H
Liver Res. 2025; 6(4):203-213.
PMID: 39957910
PMC: 11791839.
DOI: 10.1016/j.livres.2022.09.003.
Transcriptional analysis of murine biliary atresia identifies macrophage heterogeneity and subset-specific macrophage functions.
Gromer K, Chen S, Gadhvi G, Feng L, Shearn C, Antala S
Front Immunol. 2025; 16:1506195.
PMID: 39949768
PMC: 11821939.
DOI: 10.3389/fimmu.2025.1506195.
Spatial dimension of macrophage heterogeneity in liver diseases.
Guillot A, Tacke F
eGastroenterology. 2025; 1(1):e000003.
PMID: 39944246
PMC: 11770455.
DOI: 10.1136/egastro-2023-000003.
Liver diseases: epidemiology, causes, trends and predictions.
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z
Signal Transduct Target Ther. 2025; 10(1):33.
PMID: 39904973
PMC: 11794951.
DOI: 10.1038/s41392-024-02072-z.
Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization.
Zhang H, Gao M, Wang H, Zhang J, Wang L, Dong G
Sci Rep. 2025; 15(1):4015.
PMID: 39893238
PMC: 11787394.
DOI: 10.1038/s41598-025-86977-x.
Ebastine-mediated destabilization of E3 ligase MKRN1 protects against metabolic dysfunction-associated steatohepatitis.
Kim S, Han H, Rho H, Kang S, Mukherjee S, Kim J
Cell Mol Life Sci. 2025; 82(1):66.
PMID: 39888429
PMC: 11785899.
DOI: 10.1007/s00018-024-05535-2.
Increased serum GM-CSF at diagnosis of biliary atresia is associated with improved biliary drainage.
Taylor S, Harpavat S, Gromer K, Andreev V, Loomes K, Bezerra J
Pediatr Res. 2025; .
PMID: 39881181
DOI: 10.1038/s41390-025-03804-9.
AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion.
Kim J, Kurial S, Choksi P, Nunez M, Lunow-Luke T, Bartel J
Nat Biotechnol. 2025; .
PMID: 39881029
DOI: 10.1038/s41587-024-02523-6.
Potential therapeutic strategies for MASH: from preclinical to clinical development.
Xie Z, Li Y, Cheng L, Huang Y, Rao W, Shi H
Life Metab. 2025; 3(5):loae029.
PMID: 39872142
PMC: 11749562.
DOI: 10.1093/lifemeta/loae029.
Single-cell transcriptomic analysis reveals characteristic feature of macrophage reprogramming in liver Mallory-Denk bodies pathogenesis.
Fang Z, Zhong B, Shi Y, Zhou W, Huang M, French S
J Transl Med. 2025; 23(1):77.
PMID: 39819676
PMC: 11740356.
DOI: 10.1186/s12967-024-05999-7.
CAR-T therapy toxicities: the importance of macrophages in their development and possible targets for their management.
Norton J, Stiff P
Discov Oncol. 2025; 16(1):49.
PMID: 39812904
PMC: 11735762.
DOI: 10.1007/s12672-025-01776-0.
Metabolic Reprograming of Macrophages: A New Direction in Traditional Chinese Medicine for Treating Liver Failure.
Zhang J, Li N, Hu X
J Immunol Res. 2025; 2024():5891381.
PMID: 39741958
PMC: 11688140.
DOI: 10.1155/jimr/5891381.
Mechanical Force-Induced cGAS Activation in Carcinoma Cells Facilitates Splenocytes into Liver to Drive Metastasis.
Zhang X, Huang N, Mu Y, Chen H, Zhu M, Zhang S
Adv Sci (Weinh). 2024; 12(8):e2401127.
PMID: 39737867
PMC: 11848607.
DOI: 10.1002/advs.202401127.
Association between the lymphocyte-to-high-density lipoprotein ratio and metabolic dysfunction-associated steatotic liver disease among US adults: a cross-sectional study from NHANES 2017 to 2020.
Tang C, Peng D, Zong K, Wu Z, Gong M, Li H
BMC Gastroenterol. 2024; 24(1):470.
PMID: 39716074
PMC: 11667913.
DOI: 10.1186/s12876-024-03565-5.
A new human autologous hepatocyte/macrophage co-culture system that mimics drug-induced liver injury-like inflammation.
Zimmermann A, Scheffschick A, Hansel R, Borchardt H, Liu J, Ehnert S
Arch Toxicol. 2024; 99(3):1167-1185.
PMID: 39710784
PMC: 11821741.
DOI: 10.1007/s00204-024-03943-8.
Immunology and treatments of fatty liver disease.
Tang S, Wu S, Zhang W, Ma L, Zuo L, Wang H
Arch Toxicol. 2024; 99(1):127-152.
PMID: 39692857
DOI: 10.1007/s00204-024-03920-1.